Two prominent players often find themselves at the center of a heated debate: Big Pharma and Pharmacy Benefit Managers (PBMs). While distinct in their functions, these entities are deeply intertwined in the complex web of medication pricing and distribution. As the healthcare landscape evolves, questions arise about their ability to coexist harmoniously or whether the relentless pressure of costs squeezes them out of the equation altogether.